Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 6/20 | 0.39 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.35 |
| ▸ | RXFP4 | Q8TDU9 | 2/20 | 0.35 |
| ▸ | RXFP3 | Q9NSD7 | 2/20 | 0.35 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.34 |
| ▸ | NPY4R | P50391 | 1/20 | 0.34 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.34 |
| ▸ | FURIN | P09958 | 1/20 | 0.34 |
| ▸ | VIPR2 | P41587 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2367832 | 0.99 | RXFP1 (0.37) | RXFP1KEAP1RXFP4RXFP3NPY4R | |
| SCHEMBL2367091 | 0.95 | RXFP1 (0.41) | RXFP1KEAP1PTH1RNPY4RVIPR2 | |
| SCHEMBL2371869 | 0.95 | RXFP1 (0.36) | RXFP1KEAP1RXFP4RXFP3PTH1R | |
| SCHEMBL2368042 | 0.95 | RXFP1 (0.44) | RXFP1KEAP1PTH1RNPY4RPRSS1 | |
| SCHEMBL2367458 | 0.94 | RXFP1 (0.35) | RXFP1KEAP1RXFP4RXFP3PTH1R | |
| SCHEMBL2367313 | 0.93 | NPY4R (0.42) | RXFP1KEAP1NPY4RPRSS1FURIN | |
| SCHEMBL2366814 | 0.92 | RXFP1 (0.42) | RXFP1KEAP1PTH1RNPY4RPRSS1 | |
| SCHEMBL2367128 | 0.91 | NPY4R (0.41) | RXFP1KEAP1PTH1RNPY4RVIPR2 | |
| SCHEMBL3046711 | 0.91 | RXFP1 (0.40) | RXFP1KEAP1RXFP4RXFP3PTH1R | |
| SCHEMBL2367191 | 0.90 | NPY4R (0.43) | KEAP1NPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2007794-B1 | LYSOBACTIN AMIDES | AICURIS GMBH & CO KG (DE) | 2011-09-14 | — | — | EP | disclosed |